Trial Profile
Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Rifabutin (Primary) ; Lopinavir/ritonavir
- Indications HIV infections; Mycobacterium avium complex infections
- Focus Adverse reactions; Pharmacokinetics
- 13 Nov 2015 Status changed from recruiting to discontinued as per results published at The Journal of antimicrobial chemotherapy
- 16 Dec 2010 New trial record